tradmap

FRNM Freenome, Inc.

$16.35 -3.08%

Updated

Healthcare · Services-Medical Laboratories

Freenome, Inc. (FRNM) is a healthcare company in the Services-Medical Laboratories industry, with a market capitalization of $107 million. Shares last traded at $16.35, 4.6% below their 52-week high.

Market Cap
$107M
Shares Out
6.5M
EPS (TTM)
P/E Ratio
P/S Ratio
P/B Ratio
Dividend / Share
Dividend Yield
52-Week High
$17.14
52-Week Low
$9.99
Volume
33,869
Avg Vol (3m)
66,306.471

Performance

1W
+10.70%
1M
+50.34%
3M
6M
YTD
+24.57%
1Y

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
70.65
SMA (50)
SMA (200)
Price vs SMA50
Price vs SMA200
ATR (14)
$0.80

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
Net Income
$-1M
Gross Margin
Operating Margin
Net Margin
Return on Equity
12.1%
Return on Assets
-0.9%
Current Ratio
0.20
Debt / Equity
-1.12
Revenue Growth (YoY)

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Services-Medical Laboratories peers

FRNM vs 14 industry peers (Services-Medical Laboratories), by market cap. Updated

1–14 of 14
NTRANatera, Inc.$47.2B-245.2617.43-7.1%+0.66%
LHLabcorp$26.9B26.821.877.0%-0.07%
DGXQuest Diagnostics$26.4B24.882.299.2%-0.58%
GHGuardant Health, Inc.$21.6B-47.6518.26-38.3%-1.23%
CAICaris Life Sciences, Inc.$7.2B68.067.2310.6%+2.14%
RDNTRadnet, Inc.$5.9B-278.182.59-0.9%-1.36%
CELCCelcuity Inc.$4.7B-20.82+0.06%
BLLNBilliontoone, Inc.$4.6B121.8611.569.5%+3.64%
GRALGrail, Inc.$3.6B-9.19+0.03%
VCYTVeracyte, Inc.$3.6B31.356.3920.4%-0.65%
CDNACaredx, Inc.$2.6B23.225.6324.2%+0.44%
PSNLPersonalis, Inc.$1.8B-16.77+0.51%
FTREFortrea Holdings Inc.$1.8B-20.770.66-3.2%+1.47%
LMRILumexa Imaging Holdings, Inc.$1.1B-1.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.